Ingredion (INGR) EBT (2009 - 2026)

Ingredion (INGR) has reported EBT for 18 consecutive years, with $175.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBT fell 32.43% year-over-year to $175.0 million; the trailing twelve-month figure through Jun 2026 stood at $817.0 million (down 14.09% YoY), and the FY2025 full-year result was $974.0 million, up 4.62% from the prior year.
• EBT slipped to $175.0 million in Q2 2026 per INGR's latest filing, from $194.0 million in the prior quarter.
• Across five years, EBT topped out at $276.0 million in Q1 2024 and bottomed at $124.0 million in Q4 2022.
• Historically, EBT has averaged $210.1 million across 5 years, with a median of $201.5 million in 2022.
• The sharpest annual moves came in 2022 and 2026: EBT soared 199.47% in 2022, then tumbled 32.43% in 2026.
• Over 5 years, EBT stood at $124.0 million in 2022, then soared by 41.94% to $176.0 million in 2023, then dropped by 13.64% to $152.0 million in 2024, then soared by 36.18% to $207.0 million in 2025, then slipped by 15.46% to $175.0 million in 2026.
• According to Business Quant data, EBT over the past three periods registered $175.0 million, $194.0 million, and $207.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.